Join
Live feed
·
PRReleasevia Quantisnow
Orchard Therapeutics plc logo

Orchard Therapeutics Announces Positive Clinical and Preclinical Data in Programs Targeting Neurometabolic and CNS Disorders at ASGCT

ByQuantisnow·Wall Street's wire, on your screen.
ORTX· Orchard Therapeutics plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ORTX (Orchard Therapeutics plc) and more on Quantisnow.